Repligen | RGEN - Current Assets

Stock Price
135.68
Daily Change
-1.54 -1.12%
Monthly
-20.17%
Yearly
-14.66%
Q1 Forecast
131.47

Repligen reported $1.1B in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Agilent USD 4.59B 341M Sep/2025
Align Technology USD 2.62B 82.47M Dec/2025
Bio Techne USD 637.43M 27.92M Dec/2025
BioMarin Pharmaceutical USD 3.85B 49.21M Sep/2025
Bristol-Myers Squibb USD 35.63B 2.41B Sep/2025
Bruker USD 2.21B 138.1M Dec/2025
Charles River Laboratories USD 1.45B 85.06M Dec/2025
Danaher USD 12.76B 3.15B Dec/2025
Dentsply International USD 2.07B 106M Sep/2025
Exact Sciences USD 1.56B 34.88M Dec/2025
General Electric Aerospace USD 40.6B 522M Dec/2025
Henry Schein USD 4.4B 152M Sep/2025
Illumina USD 3.29B 493M Dec/2025
IQVIA Holdings USD 6.25B 270M Dec/2025
Mettler Toledo International USD 1.36B 81.46M Dec/2025
Myriad Genetics USD 344.8M 60.5M Sep/2025
OraSure Technologies USD 283.01M 18.43M Sep/2025
Pacific Biosciences Of California USD 394.24M 19.16M Sep/2025
Pfizer USD 46.92B 3.22B Sep/2025
Repligen USD 1.1B 39.62M Sep/2025
Revvity USD 2.24B 95.96M Dec/2025
Standard Biotools USD 472.44M 33.6M Sep/2025
Thermo Fisher Scientific USD 28.71B 6.41B Dec/2025
Waters USD 1.99B 69.86M Dec/2025
West Pharmaceutical Services USD 1.98B 154.9M Dec/2025